Clinical Trial: A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07007091) titled 'A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants' on May 28.

Brief Summary: This study will assess the pharmacokinetics and relative Bioavailability of risankizumab following subcutaneous administration with an on-body injector relative to a prefilled syringe

Study Start Date: June 02

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Risankizumab

Subcutaneous (SC) Injection

DRUG: Risankizumab

On-Body Injector (OBI)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbV...